| Secondary |
| Hypertension |
27.0% |
| Atrial Fibrillation |
8.7% |
| Cardiac Failure |
6.4% |
| Chronic Obstructive Pulmonary Disease |
6.0% |
| Diabetes Mellitus |
6.0% |
| Drug Use For Unknown Indication |
5.1% |
| Prophylaxis |
5.0% |
| Thrombosis Prophylaxis |
3.6% |
| Essential Hypertension |
3.3% |
| Suicide Attempt |
3.3% |
| Sleep Disorder |
3.1% |
| Supraventricular Tachycardia |
2.9% |
| Coronary Artery Disease |
2.8% |
| Product Used For Unknown Indication |
2.8% |
| Renal Failure |
2.8% |
| Hyperuricaemia |
2.5% |
| Grand Mal Convulsion |
2.3% |
| Rash |
2.3% |
| Hypercholesterolaemia |
2.2% |
| Renal Impairment |
2.0% |
|
| Toxic Epidermal Necrolysis |
12.7% |
| Vomiting |
9.5% |
| Bradyarrhythmia |
7.9% |
| Renal Failure Acute |
6.3% |
| Swollen Tongue |
6.3% |
| Atrial Fibrillation |
4.8% |
| Death |
4.8% |
| Hypertensive Crisis |
4.8% |
| Nausea |
4.8% |
| Somnolence |
4.8% |
| Toxicity To Various Agents |
4.8% |
| Acute Hepatic Failure |
3.2% |
| Bradycardia |
3.2% |
| Depression |
3.2% |
| Drug Interaction |
3.2% |
| General Physical Health Deterioration |
3.2% |
| Glycosylated Haemoglobin Increased |
3.2% |
| Hypercalcaemia |
3.2% |
| Pruritus |
3.2% |
| Renal Impairment |
3.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
24.2% |
| Hypertension |
16.2% |
| Product Used For Unknown Indication |
15.9% |
| Atrial Fibrillation |
7.1% |
| Cardiac Failure |
5.2% |
| Prophylaxis |
4.0% |
| Diabetes Mellitus |
3.3% |
| Type 2 Diabetes Mellitus |
2.9% |
| Anaesthesia |
2.3% |
| Pain |
1.9% |
| Thrombosis Prophylaxis |
1.9% |
| B-cell Lymphoma |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Coronary Artery Disease |
1.8% |
| Hyperparathyroidism Secondary |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Tachyarrhythmia |
1.7% |
| Cardiac Failure Chronic |
1.6% |
| Dyspnoea |
1.5% |
| Chronic Lymphocytic Leukaemia |
1.4% |
|
| Renal Failure Acute |
7.7% |
| Thrombocytopenia |
7.7% |
| Transaminases Increased |
6.4% |
| Cardiac Failure |
5.8% |
| Drug Interaction |
5.8% |
| General Physical Health Deterioration |
5.8% |
| Myocardial Infarction |
5.8% |
| Pyrexia |
5.8% |
| Renal Failure |
5.8% |
| Septic Shock |
5.1% |
| Gastrointestinal Haemorrhage |
4.5% |
| Somnolence |
4.5% |
| Cardiogenic Shock |
3.8% |
| Cerebrovascular Accident |
3.8% |
| Sepsis |
3.8% |
| Tachyarrhythmia |
3.8% |
| Vomiting |
3.8% |
| Weight Decreased |
3.8% |
| Death |
3.2% |
| Dyspnoea |
3.2% |
|
| Interacting |
| Hypertension |
40.7% |
| Type 2 Diabetes Mellitus |
17.5% |
| Drug Use For Unknown Indication |
9.0% |
| Pain |
6.2% |
| Glaucoma |
5.6% |
| Hyperlipidaemia |
5.6% |
| Ischaemic Heart Disease Prophylaxis |
5.6% |
| Tachyarrhythmia |
2.8% |
| Atrial Fibrillation |
1.1% |
| Prophylaxis |
1.1% |
| Acidosis |
0.6% |
| Anaemia |
0.6% |
| Cardiac Failure |
0.6% |
| Helicobacter Gastritis |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Hyperparathyroidism Secondary |
0.6% |
| Hyperuricaemia |
0.6% |
| Pyelonephritis |
0.6% |
|
| Renal Failure Acute |
60.0% |
| Vomiting |
13.3% |
| Hyponatraemia |
6.7% |
| Hypovolaemia |
6.7% |
| Renal Failure Chronic |
6.7% |
| Torsade De Pointes |
6.7% |
|
